Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-26 Sale |
2023-09-26 4:30 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
24,089 | $0 | $0 | 0 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-07 4:11 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
406 | $169.2 | $68,695 | 24,089 (Direct) |
View |
| 2023-08-15 Sale |
2023-08-17 4:31 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
403 | $168.72 | $67,995 | 24,495 (Direct) |
View |
| 2023-06-14 Sale |
2023-06-16 4:03 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
2,343 | $102.11 | $239,248 | 48,336 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:26 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
1,086 | $85.37 | $92,714 | 25,679 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 5:08 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
165 | $84.58 | $13,956 | 26,765 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 4:31 pm |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
820 | $87.47 | $71,725 | 26,930 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-12 Option Award |
2025-01-14 4:06 pm |
N/A 2035-01-12 |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-09-11 Option Award |
2024-09-13 5:26 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
22,026 | $22.7 | 131,426 (Direct) |
View |
| 2024-04-02 Option Award |
2024-04-04 5:47 pm |
N/A 2034-04-02 |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
600,000 | $0 | 600,000 (Direct) |
View |
Ownership |
2024-04-04 5:43 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Anand Bhaskar Chief Accounting Officer |
0 | $0 | 109,400 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 4:03 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
1,562 | $0 | 48,336 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 4:03 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
1,562 | $27.32 | 48,336 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 5:15 pm |
N/A 2032-05-20 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar SVP, Chief Accounting Officer |
9,000 | $0 | 33,750 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:07 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar VP, Chief Accounting Officer |
41,750 | $0 | 58,250 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:10 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar VP, Chief Accounting Officer |
37,500 | $0 | 41,500 (Direct) |
View |
Ownership |
2021-11-15 10:16 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Anand Bhaskar VP, Chief Accounting Officer |
0 | $0 | 19,000 (Direct) |
View |